Status:
COMPLETED
Improving Outcomes for Hemodialysis Patients
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Satellite Healthcare
Conditions:
Quality of Life
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
End stage renal disease (ESRD) affects approximately 700,000 Americans of which approximately 400,000 are on life-saving hemodialysis therapy. Hemodialysis can take a physical and emotional toll on pa...
Detailed Description
Hemodialysis (HD) patients have worse health related quality of life (HrQOL) than patients with any other chronic illness. In this population, poor quality of life and depressive symptoms (a major com...
Eligibility Criteria
Inclusion
- Adult patients on hemodialysis for at least 3 months
- Most recent 36-question Kidney Disease Quality of Life (KDQOL-36), Physical Component Summary (PCS), or Mental Component Summary (MCS) score below 50
- KDQOL-36 burden of disease score 80
- Expected survival 6 months
- English-speaking
Exclusion
- Bipolar or Psychotic disorder
- Moderate or severe cognitive impairment as determined by the hemodialysis staff or documented in the electronic medical record (EMR)
- Severe vision or hearing impairment
- Drug or alcohol dependence
- Active suicidal ideation or a history of suicide attempt (determined based on screening patient health questionnaire-9 and EMR)
- Current participation in a behavioral or education treatment program
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03395366
Start Date
May 1 2018
End Date
April 28 2020
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DaVita Columbia University Dialysis
New York, New York, United States, 10032